Cargando…

High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis

The human kallikrein-related peptidases (KLK) are serine proteases whose concentrations are often abnormal in common human malignancies and contribute to neoplastic progression through multifaceted roles. However, little attention has been paid to their synthesis and involvement in the development a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nathalie, Heuzé-Vourc’h, Chris, Planque, Serge, Guyetant, Catherine, Coco, Benjamin, Brillet, Claire, Blechet, Christelle, Parent, Briollais, Laurent, Pascale, Reverdiau, Marie-Lise, Jourdan, Yves, Courty
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2009
Materias:	Molecular Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516548/ https://www.ncbi.nlm.nih.gov/pubmed/19426157 http://dx.doi.org/10.1111/j.1582-4934.2009.00763.x

Ejemplares similares

Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer()
por: Lavergne, Marion, et al.
Publicado: (2013)

Human kallikrein-related peptidase 12 stimulates endothelial cell migration by remodeling the fibronectin matrix
por: Kryza, T., et al.
Publicado: (2018)

TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through tumour-stromal cell interactions
por: Gaud, Guillaume, et al.
Publicado: (2011)

Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer
por: Rollin, J, et al.
Publicado: (2005)

Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis
por: Dalloneau, Emilie, et al.
Publicado: (2016)

Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients
por: Gong, Weiwei, et al.
Publicado: (2020)

Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!
por: Sécher, Thomas, et al.
Publicado: (2019)

Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
por: Pitiot, Aubin, et al.
Publicado: (2022)

Immune Checkpoint and Anti-Angiogenic Antibodies for the Treatment of Non-Small Cell Lung Cancer in the European Union and United States
por: Ferreira, Marion, et al.
Publicado: (2021)

Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?
por: Guillon, Antoine, et al.
Publicado: (2017)

Tenascin-W is a better cancer biomarker than tenascin-C for most human solid tumors
por: Brellier, Florence, et al.
Publicado: (2012)

The Intracellular Localization of ID2 Expression Has a Predictive Value in Non Small Cell Lung Cancer
por: Rollin, Jérôme, et al.
Publicado: (2009)

Correction: Inhibition of Wnt/β-Catenin Signaling by a Soluble Collagen-Derived Frizzled Domain Interacting with Wnt3a and the Receptors Frizzled 1 and 8
por: Hendaoui, Ismaïl, et al.
Publicado: (2012)

Inhibition of Wnt/β-Catenin Signaling by a Soluble Collagen-Derived Frizzled Domain Interacting with Wnt3a and the Receptors Frizzled 1 and 8
por: Hendaoui, Ismaïl, et al.
Publicado: (2012)

Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment
por: Castaneda, Diana Cadena, et al.
Publicado: (2018)

Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs)
por: Goettig, Peter, et al.
Publicado: (2010)

Metastasis of ovarian cancer is mediated by kallikrein related peptidases
por: Dong, Ying, et al.
Publicado: (2013)

Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes
por: Stefanini, Ana Carolina B., et al.
Publicado: (2015)

Involvement of Kallikrein-Related Peptidases in Nervous System Disorders
por: Mella, Cinthia, et al.
Publicado: (2020)

Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model
por: Chesnay, Adélaïde, et al.
Publicado: (2022)

Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological Effects
por: Sécher, Thomas, et al.
Publicado: (2022)

Expression of kallikrein-related peptidase 7 is decreased in prostate cancer
por: Zhang, Chong-Yu, et al.
Publicado: (2015)

Kallikrein-related peptidase 13 expression and clinicopathological features in lung squamous cell carcinoma
por: Sumiya, Ryusuke, et al.
Publicado: (2023)

Kallikrein‐related peptidase 4 induces cancer‐associated fibroblast features in prostate‐derived stromal cells
por: Kryza, Thomas, et al.
Publicado: (2017)

Inhaled antibodies: formulations require specific development to overcome instability due to nebulization
por: Mayor, Alexie, et al.
Publicado: (2021)

Therapeutic Antibodies for the Treatment of Respiratory Tract Infections—Current Overview and Perspectives
por: Mayor, Alexie, et al.
Publicado: (2021)

Expression and function of the Kallikrein-related peptidase 6 in the human melanoma microenvironment
por: Krenzer, Stefanie, et al.
Publicado: (2011)

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
por: Talieri, M, et al.
Publicado: (2009)

Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy
por: Cao, Buqing, et al.
Publicado: (2016)

Radioimmunotherapy of prostate cancer targeting human kallikrein-related peptidase 2
por: Vilhelmsson Timmermand, O., et al.
Publicado: (2016)

Erratum: Kallikrein-related peptidase 8 is expressed in myocardium and induces cardiac hypertrophy
por: Cao, Buqing, et al.
Publicado: (2016)

Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application
por: Fuhrman-Luck, Ruth A., et al.
Publicado: (2014)

Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer
por: Du, Jian Ping, et al.
Publicado: (2018)

Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Candido, Juliana B., et al.
Publicado: (2021)

Human Tissue Kallikreins-Related Peptidases Are Targets for the Treatment of Skin Desquamation Diseases
por: Zani, Marcelo B., et al.
Publicado: (2022)

Targeting Aspergillus fumigatus Crf Transglycosylases With Neutralizing Antibody Is Relevant but Not Sufficient to Erase Fungal Burden in a Neutropenic Rat Model
por: Chauvin, David, et al.
Publicado: (2019)

Doxycycline Indirectly Inhibits Proteolytic Activation of Tryptic Kallikrein-Related Peptidases and Activation of Cathelicidin
por: Kanada, Kimberly N., et al.
Publicado: (2012)

Structural basis for the Zn(2+) inhibition of the zymogen-like kallikrein-related peptidase 10
por: Debela, Mekdes, et al.
Publicado: (2016)

A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis
por: Du, Jian-Kui, et al.
Publicado: (2021)

The diagnostic and prognostic value of serum human kallikrein-related peptidases 11 in non-small cell lung cancer
por: Xu, Chun-Hua, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rth2i1b5p809gktssrdnjhvn4v